
GENB vs ZYME
$GENB vs $ZYME head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GENB vs ZYME: the quick read
- ·ZYME is the larger company by market cap ($1.81B vs $1.80B).
- ·GENB has been more active on our scanner (126 vs 66 alerts in 30 days).
- ·ZYME has the smaller float (45.7M vs 58.1M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 126 and 66 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: GENB is outperforming the other by roughly 7.7 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GENB and ZYME on TheDesperateTrader.
- Is GENB or ZYME the better stock?
- "Better" depends on your goal, and these two are not alike. ZYME is the larger company by market cap ($1.81B vs $1.80B). GENB has been more active on our scanner (126 vs 66 alerts in 30 days). ZYME has the smaller float (45.7M vs 58.1M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GENB and ZYME?
- The differences that matter: they are not in the same business - GENB is pharmaceutical preparations and ZYME is pharmaceutical preparations; they are similar in size ($1.80B vs $1.81B); they trade at very different share prices ($13.97 vs $25.26); GENB sits at 25% of its 52-week range against 60% for ZYME; our scanner flagged GENB 126 times in the last 30 days against 66 for ZYME. Everything above is measured from the latest completed session and SEC filings.
- Which of GENB and ZYME is more active right now?
- Right now GENB is at about 0.8x its normal volume and ZYME is at about 1.5x, so ZYME is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GENB or ZYME? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore GENB and ZYME comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.